Titre:
  • MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.
Auteur:Cuccuini, Wendy; Briere, Josette; Mounier, Nicolas; Voelker, Hans-Ullrich; Rosenwald, Andreas; Sundstrom, Christer; Cogliatti, Sergio; Hirchaud, Edouard; Ysebaert, Loic; Bron, Dominique; Soulier, Jean; Gaulard, Philippe; Houlgatte, Remi; Gisselbrecht, C.; Thieblemont, Catherine
Informations sur la publication:Blood, 119, 20, page (4619-4624)
Statut de publication:Publié, 2012-05
Sujet CREF:Cancérologie
MeSH keywords:Adult
Aged
Antibodies, Monoclonal, Murine-Derived -- administration & dosage -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects
Carmustine -- administration & dosage -- adverse effects
Chemotherapy, Adjuvant
Cisplatin -- administration & dosage -- adverse effects
Combined Modality Therapy
Cytarabine -- administration & dosage -- adverse effects
Dexamethasone -- administration & dosage -- adverse effects
Etoposide -- administration & dosage -- adverse effects
Female
Genes, myc -- physiology
Hematopoietic Stem Cell Transplantation -- methods
Humans
Ifosfamide -- administration & dosage -- adverse effects
Immunotherapy
Lymphoma, Large B-Cell, Diffuse -- drug therapy -- genetics -- mortality -- therapy
Male
Melphalan -- administration & dosage -- adverse effects
Middle Aged
Podophyllotoxin -- administration & dosage -- adverse effects
Salvage Therapy
Transplantation, Autologous
Treatment Failure
Young Adult
Note générale:Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0006-4971
info:doi/10.1182/blood-2012-01-406033
info:pii/blood-2012-01-406033
info:scp/84861211721
info:pmid/22408263